Skip to main content
. 2020 Apr 4;10(5):193. doi: 10.1007/s13205-020-2166-x

Table 3.

List of nonneuropathic localised amyloidosis type diseases

Protein or peptide Associated disease Native structure
Amylin or Islet amyloid polypeptide (IAPP) Type II diabetes Native structure unfolded
Calcitonin Medullary carcinoma of the thyroid Native structure unfolded
ANF Atrial amyloidosis Native structure unfolded
Amyloid β peptide mutants Hereditary cerebral haemorrhage and amyloidosis Native structure unfolded
Prolactin Pituitary prolactinoma α helical and 4-helical cytokines
Insulin, Enfuviritide Injection localised amyloidosis α helical and insulin-like
Keratin Cutaneous lichen amyloidosis Not known
Amyloid β peptide Inclusion body myositis Native structure unfolded
Lung surfactant protein C Pulmonary alveolar proteinosis Not known
γ- crystallin Cataract β sheets like γ crystallin
Corneodesmosin Hypotrichosis simplex of the scalp Native structure unfolded
Lactotransferrin Corneal dystrophy gelatinous like α + β both, periplasmic binding protein II

All of the nonneuropathic localised diseases mentioned above are sporadic although hereditary forms have also been reported except hereditary cerebellar haemorrhage and pulmonary alveolar proteinosis which are predominantly genetic although sporadic forms have also been reported (Chiti and Dobson 2017)